The Anosh Inc Foundation is a nonprofit organization based in Chicago, focused on enhancing lives through programs in ...

ALK ( ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EUR neffy® 2 mg in the United Kingdom (UK) for anaphylaxis treatment of ...

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at ...

Net Profit Achieved: Q2 2025 marked Hapbee’s first profitable quarter in company history, with net income of $17,988, compared to a net loss of $178,984 in Q1 2025 and a loss of $1.86 million in Q2 ...

Each option was granted pursuant to the Aardvark Therapeutics, Inc. 2025 Inducement Equity Incentive Plan, and was granted as an inducement material to each employee’s employment with Aardvark in ...

The APOE4 gene affects 25% of the population and drives 44% of all Alzheimer's cases, creating a $181 billion annual burden in the U.S. alone. With 1.1 billion carriers worldwide facing dramatically ...

The stock options have a ten-year term and an exercise price of $2.38 per share, which is equal to the closing price of Vor Bio’s common stock on July 17, 2025. The stock options will vest over a four ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it is finalizing a significant three-year collaborative agreement ...

HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, ...

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug ...

The Company’s common stock is expected to begin trading on a split-adjusted basis when the markets open on July 22, 2025 under the Company’s existing trading symbol “GBIO” with the new CUSIP number ...

On 14 July 2025, Fagron received a notification that the shareholding of Alychlo NV, crossed the disclosure threshold of 3% downwards as the result of the disposal of voting securities or voting ...